Bajaj Healthcare Share Price Target 2026 Analyst Forecast Bull and Bear Case
- May 16, 2026
- Posted by: Kashish Aggarwal
- Category: News
The Bajaj Healthcare share price target for 2026 stands at Rs 400 as per analyst consensus, implying approximately 20 percent upside from the current market price of Rs 332. Investors tracking the Bajaj Healthcare share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings outlook, key risks, and the bull versus bear case scenarios. This article covers every dimension of the Bajaj Healthcare share price target thesis, updated May 2026.
Click Here – Get Free Investment Predictions
Bajaj Healthcare Company Overview
Bajaj Healthcare (NSE: BAJAJHCARE) is a Thane-based vertically integrated pharmaceutical manufacturer producing Active Pharmaceutical Ingredients, intermediates, finished dosage forms, and nutraceuticals from five manufacturing units in Gujarat and Maharashtra. At CMP Rs 332 against a 52 week range of Rs 273.25 to Rs 608.9, the stock currently trades at a meaningful discount to its 52 week high, creating a potential re-rating opportunity for investors focused on the Bajaj Healthcare share price target of Rs 400. The company’s market capitalisation stands at Rs 1,121 crore.
| Parameter | Value |
|---|---|
| NSE Ticker | BAJAJHCARE |
| Sector | Pharmaceuticals and APIs |
| CMP May 2026 | Rs 332 |
| 52 Week High | Rs 608.9 |
| 52 Week Low | Rs 273.25 |
| Market Cap | Rs 1,121 crore |
| Trailing P/E | 23x |
| 12M Analyst Target | Rs 400 |
| Bull Case Target | Rs 480 |
| Bear Case Target | Rs 265 |
Why Is Bajaj Healthcare Share Price Target Set at Rs 400 for 2026
FY27 Earnings Delivery and Revenue Acceleration
FY27 is the pivotal year for the earnings recovery thesis underpinning the Bajaj Healthcare share price target 2026 of Rs 400. Analysts project 15 to 20 percent PAT growth in FY27 as operational leverage and strategic investments begin contributing meaningfully to the top line. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the Bajaj Healthcare share price target forecast. This FY27 earnings delivery is the primary variable that bridges the current CMP of Rs 332 with the Bajaj Healthcare share price target of Rs 400.
Structural Sector Tailwinds in Pharmaceuticals and APIs
India’s pharmaceutical sector is growing on the back of rising healthcare expenditure, USFDA approvals, and expanding generic drug export markets globally. Bajaj Healthcare’s market position and operational expertise create a compounding growth runway that directly supports the Bajaj Healthcare share price target consensus of Rs 400. Improving sectoral fundamentals are expected to accelerate earnings momentum through FY27, reinforcing the Bajaj Healthcare share price target 2026 bull case of Rs 480.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s RBI rate cut cycle, which commenced in early 2026, reduces Bajaj Healthcare’s borrowing costs and stimulates demand across its end markets. Lower interest costs improve EBITDA to PAT conversion, directly expanding EPS and supporting the Bajaj Healthcare share price target 2026 of Rs 400. Any further rate cuts through FY27 compound this benefit and add upside optionality toward the bull case Bajaj Healthcare share price target of Rs 480.
Union Budget 2026 Policy Support
Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption demand incentives create a positive policy backdrop for Bajaj Healthcare’s Pharmaceuticals and APIs business. These policy tailwinds directly support the Bajaj Healthcare share price target 2026 bull case and improve the probability of achieving the Rs 400 analyst estimate over the next 12 months.
Improving FII Flows Post US Tariff Shock
As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the Bajaj Healthcare share price target of Rs 400. Bajaj Healthcare’s valuation at 23x P/E relative to sector peers positions it as a potential beneficiary of institutional reallocation as sentiment normalises across Indian equities.
Screen the best stocks on the Univest Screener.
Bajaj Healthcare Share Price Targets: Short Term, 12 Month, and Long Term
Short Term Target: 3 to 6 Months
The short term Bajaj Healthcare share price target is anchored to the 52 week low support zone near Rs 273.25. In the 3 to 6 month timeframe, a recovery toward 10 to 15 percent above current levels is the base case if Q4 FY26 results confirm the earnings recovery trajectory. Any positive operational update could serve as a near-term re-rating trigger toward the full Bajaj Healthcare share price target 2026 of Rs 400.
12 Month Bajaj Healthcare Share Price Target 2026
The 12 month Bajaj Healthcare share price target 2026 is Rs 400, implying approximately 20 percent upside from CMP Rs 332. This base case assumes in-line FY27 earnings delivery, partial normalisation of FII flows, and continued execution on strategic priorities. Track the live Bajaj Healthcare share price target data on NSE ticker BAJAJHCARE.
Long Term Target: FY27 to FY28
For investors with a 2 to 3 year horizon, the long term Bajaj Healthcare share price target is Rs 480 in the bull case. Full FY27 to FY28 earnings delivery, strategic expansion, and sector re-rating toward higher peer multiples are the conditions required. The long-term Bajaj Healthcare share price target thesis rests on Bajaj Healthcare’s market leadership and expanding addressable opportunity in the Pharmaceuticals and APIs space.
Bull Case and Bear Case for Bajaj Healthcare Share Price Target
Bull Case Bajaj Healthcare Share Price Target Rs 480
The bull case for the Bajaj Healthcare share price target of Rs 480 materialises if FY27 earnings exceed analyst estimates, sector tailwinds accelerate beyond consensus, and FII flows return to quality Indian names. Under this scenario, the stock re-rates toward higher earnings multiples, making the Bajaj Healthcare share price target of Rs 480 achievable within FY27 to FY28.
Bear Case Bajaj Healthcare Share Price Target Rs 265
The bear case sees the Bajaj Healthcare share price target testing Rs 265 if FY27 earnings guidance disappoints and FII outflows from Indian equities persist. At Rs 265, the stock would revisit near the 52 week low support zone of Rs 273.25, requiring a full reassessment of the Bajaj Healthcare share price target thesis before fresh targets can be assigned.
| Scenario | Price Target | Conditions |
|---|---|---|
| Bull Case | Rs 480 | FY27 earnings beat, sector re-rating, FII inflows, macro normalisation |
| Base Case Analyst Forecast | Rs 400 | In-line FY27 delivery, partial FII recovery, steady execution |
| Bear Case | Rs 265 | FY27 guidance cut, earnings miss, persistent FII outflows |
Key Risks to the Bajaj Healthcare Share Price Target 2026
US Tariff Macro Headwind
The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across Indian equities including Bajaj Healthcare. Prolonged trade tension or global demand slowdown remains a key downside risk to the Bajaj Healthcare share price target 2026 of Rs 400.
Valuation and Earnings Miss Risk
At 23x P/E, any FY27 earnings miss or guidance cut could trigger multiple compression, posing the most immediate risk to the Bajaj Healthcare share price target 2026 of Rs 400. Investors should monitor quarterly results closely for confirmation of the earnings recovery trajectory.
Competitive Pressure in Pharmaceuticals and APIs
Intensifying competition in the Pharmaceuticals and APIs space could compress Bajaj Healthcare’s pricing power and market share over the medium term. This is a structural risk that investors should weigh when evaluating the Bajaj Healthcare share price target of Rs 400 at current levels.
FII Selling Pressure and Liquidity Risk
Global risk-off events can trigger institutional selling, disconnecting price from fundamental value. Sustained FII outflows could delay re-rating toward the Bajaj Healthcare share price target regardless of company-level improvement through FY27.
How to Invest in Bajaj Healthcare
- Research the Fundamentals: Analyse Bajaj Healthcare’s quarterly results, balance sheet, and strategic developments before making any investment decision based on the Bajaj Healthcare share price target 2026 of Rs 400.
- Open a Demat Account: Buy Bajaj Healthcare (NSE: BAJAJHCARE) through any SEBI registered broker to invest with full regulatory protection.
- Plan Your Entry: Key support is near Rs 273.25 at the 52 week low. A confirmed FY27 earnings uptick would strengthen the entry case toward the Bajaj Healthcare share price target of Rs 400.
- Position Sizing: Allocate a maximum of 3 to 5 percent of your portfolio to any single stock to manage concentration and liquidity risk effectively.
- Consult a SEBI Registered Advisor: Always seek guidance from a SEBI registered financial advisor before investing based on any Bajaj Healthcare share price target estimate. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
FAQs on Bajaj Healthcare Share Price Target 2026
What is the Bajaj Healthcare share price target for 2026?
The Bajaj Healthcare share price target 2026 is Rs 400 based on analyst estimates, implying approximately 20 percent upside from the current CMP of Rs 332. The bull case is Rs 480 and the bear case is Rs 265.
Is Bajaj Healthcare a good buy at CMP Rs 332?
At Rs 332, the stock offers potential upside to the Bajaj Healthcare share price target 2026 of Rs 400 if FY27 earnings recover as projected. Investment suitability depends on individual risk tolerance and time horizon. Consult a SEBI registered financial advisor before investing.
What is the 52 week high and low of Bajaj Healthcare?
The 52 week high of Bajaj Healthcare is Rs 608.9 and the 52 week low is Rs 273.25. At CMP Rs 332, the stock is below its 52 week peak, creating upside potential to the Bajaj Healthcare share price target 2026 of Rs 400.
What are the main risks to the Bajaj Healthcare share price target?
Key risks to the Bajaj Healthcare share price target of Rs 400 include US tariff-driven FII selling, earnings miss risk, competitive pressure in Pharmaceuticals and APIs, and broader market volatility. Monitor quarterly results for confirmation of the recovery trajectory.
What are the key catalysts for the Bajaj Healthcare share price target?
Primary catalysts for the Bajaj Healthcare share price target 2026 include FY27 PAT recovery, sector tailwinds in Pharmaceuticals and APIs, RBI rate cut support, Budget policy uplift, and FII flow normalisation into quality Indian equities through FY27.
Where can I track Bajaj Healthcare live price and analyst data?
Track the Bajaj Healthcare share price target and live price on NSE (ticker: BAJAJHCARE). Financial data platforms provide quarterly results, margins, and peer comparisons to assess the Rs 400 analyst estimate thesis in real time.
What is the Bajaj Healthcare share price target for 2027?
For FY27 to FY28, the long term Bajaj Healthcare share price target is Rs 480 in the bull case, assuming earnings acceleration, sector re-rating, and FII flow recovery. Consult a SEBI registered financial advisor for personalised investment guidance.
How can I buy Bajaj Healthcare shares?
You can buy Bajaj Healthcare (NSE: BAJAJHCARE) through any SEBI registered stockbroker by opening a Demat and trading account online. Research the Bajaj Healthcare share price target on verified financial platforms and always set a disciplined entry, target, and stop loss before investing.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of May 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
